US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark
Via ACCESSWIRE
News headline image
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗
 
Via Benzinga
News headline image
The 3 Most Undervalued Penny Stocks to Buy in June 2024 ↗
Numerous penny stocks are undervalued and might benefit from elevated trading activity, given their fundamental zeal. 
Via InvestorPlace
News headline image
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
News headline image
Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024
Via ACCESSWIRE
News headline image
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels
Via ACCESSWIRE
News headline image
Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay
Via ACCESSWIRE
News headline image
Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
Via ACCESSWIRE
News headline image
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
Via ACCESSWIRE
News headline image
Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Via ACCESSWIRE
News headline image
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying ↗
 
Via Benzinga
News headline image
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform
Via ACCESSWIRE
News headline image
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning! 
Via InvestorPlace
News headline image
ZOM Stock Earnings: Zomedica Misses Revenue for Q1 2024 ↗
ZOM stock results show that Zomedica missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
Via ACCESSWIRE
News headline image
Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024
Via ACCESSWIRE
Zomedica Corp. (NYSE American: ZOM) Featured in Coverage of the EF Hutton Annual Global Conference
Via Investor Brand Network
News headline image
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
Via ACCESSWIRE
News headline image
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
Via ACCESSWIRE
News headline image
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
Via ACCESSWIRE
News headline image
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
Via ACCESSWIRE
News headline image
ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023 ↗
ZOM stock results show that Zomedica beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
Via ACCESSWIRE
News headline image
Earnings Scheduled For April 1, 2024 ↗
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. 
Via Benzinga
News headline image
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Via ACCESSWIRE
News headline image
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Via ACCESSWIRE
News headline image
Zomedica Provides NYSE American Listing Update
Via ACCESSWIRE
News headline image
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
Via ACCESSWIRE
News headline image
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >